Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells

Arzneimittelforschung

2005 • 8,820 citations

A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone

1987 • 2,769 citations

Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

1985 • 2,616 citations

Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced Cancer

1987 • 1,224 citations

In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2.

1985 • 600 citations

High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer

1986 • 459 citations

In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2.

1985 • 368 citations

Clinical effects and toxicity of interleukin-2 in patients with cancer

1986 • 359 citations

Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease.

1986 • 144 citations

Systemic administration of interleukin-2 in humans.

1984 • 78 citations

Toxicity of recombinant human interleukin-2 in rats following intravenous infusion.

1985 • 54 citations

Lysis of primary hepatic tumours by lymphokine activated killer cells.

1987 • 22 citations

Effect of detergents on the enzyme activities of the rat liver plasma membrane

1974 • 20 citations